首页> 外文期刊>American pharmaceutical review >Lipid-based oral drug delivery systems to enhance solubility and absorption of poorly water-soluble drugs: Drug delivery
【24h】

Lipid-based oral drug delivery systems to enhance solubility and absorption of poorly water-soluble drugs: Drug delivery

机译:基于脂质的口服药物输送系统,可增强水溶性差的药物的溶解性和吸收性:药物输送

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: The aim of this study was to identify the factors that contribute to the decision to choose single embryo transfer (SET). Methods: Two hundred and nine patients who underwent ART treatment in our clinics between April 2006 and May 2007 were enrolled in this study. All patients had elected to undergo SET before the start of each treatment cycle; a questionnaire was administered to all patients prior to the SET procedure. Results: The mean age of the patients was 34.6 years old (range: 24-45 years). The mean number of redundant embryos was 3.7 (range: 1-17), and the pregnancy rate per embryo transfer was 25.7%. A total of 121 patients (57.9%) who underwent SET returned their questionnaires. Based on the results of questionnaire, 56.2% of patients who received SET waived their right to choose between single and double embryo transfer. Among patients who selected SET, 67.6% believed that the pregnancy rate resulting from double embryo transfer (DET) is significantly greater than that associated with SET, and 25% of patients wanted to have twins. The majority of patients (80.9%) who underwent SET understood that multi-fetal pregnancy increases the risk of complications during gestation and delivery. Among all patients who completed the questionnaire, 72.8% believed that the number of transferred embryos should not be controlled by law. Conclusions: The results of the present study show that greater than one-half of patients who underwent SET were faced with a dilemma - the difficult choice between their own desires and their clinician's recommendation.
机译:目的:本研究的目的是确定有助于选择单胚胎移植(SET)决定的因素。方法:纳入2006年4月至2007年5月间在我们诊所接受抗逆转录病毒治疗的299例患者。在每个治疗周期开始之前,所有患者都选择接受SET。在SET程序之前,对所有患者进行了问卷调查。结果:患者的平均年龄为34.6岁(范围:24-45岁)。多余胚胎的平均数量为3.7(范围:1-17),每次胚胎移植的受孕率为25.7%。接受SET的121例患者(57.9%)返回了问卷。根据问卷调查的结果,接受SET的患者中56.2%放弃了在单胚胎移植和双胚胎移植之间进行选择的权利。在选择SET的患者中,有67.6%的人认为双胎移植(DET)导致的妊娠率显着高于与SET相关的妊娠率,而25%的人希望生双胞胎。接受SET的大多数患者(80.9%)了解多胎妊娠会增加妊娠和分娩期间发生并发症的风险。在完成问卷调查的所有患者中,有72.8%的人认为转移的胚胎数量不应受到法律的控制。结论:本研究的结果表明,接受SET手术的患者中,有超过一半面临两难选择,即他们自己的愿望和临床医生的建议之间的艰难选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号